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It is well established that sustained increases in
cyclic AMP (cAMP) such as those triggered by for-
skolin inhibit T cell activation. We describe here an
unexpected phenomenon: in T cells, a transient
cAMP increase triggered by the interaction with
a dendritic cell strongly potentiates T cell receptor
(TCR) signaling. We discovered this effect by exam-
ining the molecular basis of the adhesion-dependent
sensitization of T cells. T cell adhesion caused extra-
cellular-signal-regulated kinase (ERK) activation,
which was necessary for the sensitization process.
T cell sensitization could be mimicked in suspended
cells by the uncaging of caged cAMP upon ultraviolet
illumination. Calcium responses occurring in T cells
upon interaction with dendritic cells were strongly
inhibited when protein kinase A activation was
blocked. Thus, whereas sustained cAMP increases
are well known to inhibit TCR signaling, transient
cAMP increases occurring physiologically upon
formation of an immunological synapse facilitate
antigen detection.
INTRODUCTION
It is well established that cAMP may act as a potent inhibitor for
the activation of T lymphocytes (Henney and Lichtenstein, 1971;
Hermann-Kleiter et al., 2006; Tamir et al., 1996; Vang et al.,
2003). Indeed, major inhibitory effects of cAMP in T cells were
systematically observed after massive and sustained cAMP
increases triggered by permeant forms of cAMP, by forskolin,
a pharmacological activator of adenylate cyclase, or by prosta-
glandin E2, which also activated adenylate cyclase. The inhibi-
tory effects could be exerted on gene transcription through the
ubiquitous transcription factor CREB (cAMP-response element
binding protein), which binds to CRE, the cAMP response
element, and which, after phosphorylation by protein kinase A
(PKA), modulates the transcription of different genes necessary
for full T cell activation (Bodor et al., 2001). The inhibitory effect
of cAMP could also be exerted much earlier in T cell signaling.
Thus, it has been shown that prostaglandins could inhibit thecalcium response triggered by lectins (Choudhry et al., 1999).
In summary, the dominant paradigm is that cAMP acts as
a potent inhibitor of T cell signaling.
In the present paper we reveal an unexpected role for cAMP
and demonstrate that under physiological conditions, T cell
signaling includes a cAMP-dependent amplification step.
We have discovered this paradoxical effect by examining the
molecular basis, and in particular the extracellular-signal-
regulated kinase (ERK) dependence, of the phenomenon called
adhesion-induced T cell priming (AITCP). This phenomenon
describes the fact that, in T cells, the transition from a suspended
to an adherent state is rapidly accompanied by a rise in the
sensitivity of the TCR signaling cascade (Randriamampita
et al., 2003; Trautmann and Randriamampita, 2003). This allows
T cells to be sensitive to an extremely small number of MHC-
peptide complexes bound to the surface of antigen-presenting
cells (APCs) (Ma et al., 2008). Such an adhesion-induced change
in sensitivity is expected to take place once T cells have entered
secondary lymphoid organs or inflamed tissues, where antigen
recognition may take place. Experimentally, AITCP has been
demonstrated after T cell adhesion to glass, to immobilized b2
integrin antibodies, to APCs such as dendritic cells (DCs) (Ran-
driamampita et al., 2003), or to fibronectin (Doucey et al.,
2003). Many phenomena are triggered by T cell adhesion, and
in particular phosphorylation of tyrosine kinases such as Pyk2,
Lck, and Fyn and of the cytoskeleton-associated molecule
paxillin (Doucey et al., 2003). The importance of ERK in AITCP
has not been explored so far. However, it is well known that
adhesion results in ERK activation in fibroblasts and endothelial
cells, a phenomenon mediated by integrins (Aplin et al., 1998). In
different cell types, a number of cellular responses, such as cell
differentiation, survival, proliferation, and altered metabolism are
under the control of a phosphorylation cascade leading to ERK
activation. Once phosphorylated, ERK becomes active and
can phosphorylate a large set of substrates in the plasma
membrane, the cytosol, and the nucleus, and this switches on
an array of genes. Several layers of regulation contribute to the
control of ERK activity (Murphy and Blenis, 2006). For instance,
after integrin activation, modulation of protein phosphatase
activity has been proposed to contribute to ERK activation in T
lymphocytes (Chetoui et al., 2006; Laakko and Juliano, 2003).
HePTP (hematopoietic protein tyrosine phosphatase) is an ERK
phosphatase predominantly expressed in thymocytes and T
lymphocytes (Zanke et al., 1992). HePTP binds andImmunity 30, 33–43, January 16, 2009 ª2009 Elsevier Inc. 33
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ylated by protein kinase A (PKA) on Ser-23 (Saxena et al., 1999a;
Saxena et al., 1999b). Such a phosphorylation event has been
reported to take place after TCR stimulation (Nika et al., 2004)
but has never been described after integrin stimulation.
Although the inhibitory effect exerted on T cell signaling after
a massive and sustained cAMP increase is undisputable, we
demonstrate here that one must now take into account the
existence of an opposite, facilitating effect of early, transient
cAMP increases occurring physiologically upon interaction
with an antigen-presenting cell. This potentiating effect of
cAMP is mediated by ERK and is due to the fact that at least
one ERK phosphatase is inhibited by cAMP. This early,
antigen-independent ERK activation is likely to lower the
threshold for antigen detection at the immunological synapse
and to occur repeatedly during the sojourn of T cells within lymph
nodes.
RESULTS
ERK Activated after T Cell Adhesion Influences T Cell
Sensitization
In an attempt to understand why T cell signaling was so efficient
in adherent T cells, we compared the behavior of suspended
T cells to that of T cells adhering on fibronectin (or on DCs, for
a subset of experiments). We have first examined the involve-
ment of the ERK cascade, known to be activated after adhesion
in various cell types. The calcium response elicited by anti-CD3
was larger in T cells adherent on fibronectin than in suspended
T cells, and this adhesion-induced potentiation of the calcium
response was abolished when adherent T cells were pretreated
with the MEK inhibitor U0126 (Figure 1A).
Next, we examined whether T cell adhesion was sufficient to
activate ERK. A minor fraction of ERK is already phosphorylated
in suspended cells, and this amount was substantially increased
after T cell adhesion (Figure 1B). The amount of phospho-ERK2
was generally larger than that of phospho-ERK1. Kinetic
experiments show that after adhesion, the degree of ERK phos-
phorylation increased rapidly, peaked at around 10 min, and
returned to basal level within 20 min (Figure 1B). The adhesion-
dependent increase in phospho-ERK measured at 5 min was
completely abolished in T cells that had been pretreated with
U0126 (Figure 1C). Taken together, these results indicate that
ERK is activated by T cell adhesion and that this activation is
necessary for adhesion-induced T cell priming.
ERK Activation after Adhesion Results
from the Inhibition of Protein Phosphatases
We next investigated the mechanism by which T cell adhesion
leads to ERK activation. Because ERK activity is directly linked
to its degree of phosphorylation, this activity is settled by the
balance between the activities of MEK, which phosphorylates
ERK, and those of the phosphatases that dephosphorylate it.
Because an increase of ERK phosphorylation may be due to
an increase in MEK activity and/or to a decrease in phosphatase
activity, we examined both possibilities.
We first tested whether T cell adhesion induced a change in
the phosphorylation of MEK. By using specific antibodies
directed against the phosphorylated forms of MEK, we34 Immunity 30, 33–43, January 16, 2009 ª2009 Elsevier Inc.compared the degree of phospho-MEK in suspended or
adherent T cells. A marked increase in MEK phosphorylation
was measured after stimulation with a phorbol ester, used as
a positive control. However, T cell adhesion failed to induce
any increase in MEK phosphorylation (Figure S1 in the Supple-
mental Data available online). Instead, a small reduction of
MEK phosphorylation was consistently measured after 5 min of
adhesion.
Next, we examined whether T cell adhesion affected the rate
of ERK inactivation. ERK phosphatase activity was directly
measured in cell extracts prepared from suspended or adherent
cells. As shown in Figure 1D, adhesion induced a major inhibition
of ERK phosphatases in T cells in less than 5 min. We conclude
that the increase in active ERK triggered by adhesion is due to an
inhibition of its inactivation by phosphatases and not to the acti-
vation of the Ras-MEK cascade.
cAMP Increases after T Cell Adhesion
Given the importance of the crosstalk between the cAMP and
ERK signaling pathways (Stork and Schmitt, 2002), we next
explored whether cAMP could contribute to the increased
amount of activated ERK observed after T cell adhesion. First,
we examined whether T cell adhesion induced an increase in
cAMP.
To this end, we measured the cAMP content of T cell popula-
tions before and after adhesion. Because adhesion was per-
formed in the presence of the phosphodiesterase (PDE) inhibitor,
3-isobutyl-1-methylxanthine (IBMX), the values represent an
accumulation of cAMP upon adhesion. These measurements,
performed by HTRF (homogeneous time-resolved fluorescence;
see Supplemental Data), indicate that the intracellular cAMP
content of T cells increases after adhesion (Figure 2A). The
increase was barely detectable after 5 min and became larger
at later times. In order to achieve a better spatial and time
resolution, we switched to the fluorescence resonance energy
transfer (FRET)-based probe AKAR2 (Zhang et al., 2005; Zhang
et al., 2001). This probe detects changes in the conformation
of a fluorescent molecule after its phosphorylation by PKA,
whose activity is tightly linked to the cAMP level. Figure 2B
(upper panels) shows that changes in PKA activity measured in
individual cells expressing AKAR2 are detected within the first
minute after their adhesion to fibronectin. The average kinetics
displayed by a large number of cells showed that after adhesion
on fibronectin, PKA activity reached its maximum in less than 2
min (Figure 2B, lower panel). After the initial peak, the cAMP-
dependent FRET/CFP ratio slowly declined and returned to
basal value within 10 min. These kinetics are in contrast with
the sustained cAMP increase that may be measured after stim-
ulation with forskolin plus IBMX (Figure S2A). Thus, thanks to
a FRET-based probe, we have detected, at the single-cell level,
the existence of a transient cAMP increase triggered in T cells by
adhesion.
Priming of T Cells by Adhesion Can Be Mimicked
by a Transient Rise in cAMP Triggered by Uncaging
Photoreleasable cAMP
We then looked at whether, in suspended cells, an increase in
cAMP could mimic the potentiating effect of adhesion in CD3-
induced calcium responses. For this purpose, we first used
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Figure 1. ERK Activation upon Adhesion
on Fibronectin Is Required for AITCP
(A) Suspended (thin line) or 5 min-adherent (thick
line) 3A9 T cells were stimulated by 5 mg/ml anti-
CD3 in control conditions or in the presence of
10 mM U0126, added 10 min before the calcium
measurement. This experiment is typical of more
than six experiments.
(B) ERK was rapidly and transiently activated after
3A9 T cell adhesion as detected by immunoblotting
with antibodies directed against the phosphory-
lated form of ERK (upper panel). This activation
was quantified relative to the amount of Sam68
used as a control in the same lane (lower panel).
This experiment is typical of more than 15 experi-
ments.
(C) ERK activation measured after 5 min of adhe-
sion was completely blocked in cells preincubated
with U0126.
(D) The ability of a 3A9 T cell extract to dephosphor-
ylate exogenous p-ERK decreased upon adhesion.
Values are expressed relative to the value
measured in suspended cells (t = 0). Each point
corresponds to the mean ± SD of three to five inde-
pendent experiments.
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A Transient Rise in cAMP Sensitizes TCR Signalingforskolin or permeant analogs of cAMP (dibutyryl-cAMP or
8-chloro-phenyl-thio-cAMP [8CPT-cAMP]). When applied on
suspended cells, these agents never potentiated calcium
responses, but rather they inhibited them (Figures S2B and
S2C). Similarly, when we attempted to amplify the potentiating
effect of adhesion by adding IBMX during the adhesion phase,
AITCP was blocked (Figure S2D). These observations were
apparently in total contradiction to our results, which suggested
that cAMP increase was crucial for AITCP establishment. In
order to test whether the kinetics of the cAMP increase were
a key factor for AITCP, we used 4,5-dimethoxy-2-notrobenzyl-
cAMP (DMNB-caged cAMP) with the aim of generating transient
cAMP increases. After UV illumination, a fraction of the intracel-
lular DMNB-caged cAMP is released, and the resulting cAMPrise is transient as a result of the activity of endogenous PDE.
As shown in the inset of Figure 3A, a 3 s UV flash induced a rapid
rise of a cAMP-dependent FRET/CFP ratio lasting only a few
minutes and was quite similar to the transient cAMP increase
triggered by cell adhesion. Anti-CD3 stimulation was performed
on cells 1–6 min after a UV flash, and the amplitude of the
calcium response was measured in cells previously loaded or
not with DMNB-caged cAMP. As shown in Figure 3A, a much
larger calcium increase was observed in T cells loaded with
DMNB-caged cAMP if anti-CD3 stimulation was performed
1 min after the flash. This potentiating effect was not long lasting.
Indeed, with 50 mM DMNB-caged cAMP, potentiation was still
detectable but smaller 3 min after cAMP release, and it disap-
peared when 6 min separated the UV flash and anti-CD3Figure 2. cAMP Increases after T Cell
Adhesion on Fibronectin
(A) cAMP measurements by HTRF on a PBT popu-
lation show that a cAMP increase was detected in
T cells treated with forskolin (FSK, 13 mM) (gray bar)
for 10 min or when T cells adhered on fibronectin
for 5–30 min (black bars). Except for the control
(white bar), 20 mM IBMX was present throughout
the experiment. Note that in suspended cells,
IBMX had a slight effect on the resting cAMP
amount (hatched bar). One experiment typical of
three experiments is shown.
(B) Top: individual 3A9 T cells transfected with the
PKA probe AKAR2 displayed upon adhesion
a rapid rise in a PKA-dependent signal, measured
as a ratio of fluorescence emitted at 535 (‘‘FRET’’)
and 470 (‘‘CFP’’) nm after a 435 nm excitation
(see Experimental Procedures). Bottom: average ±
SEM of adhesion-induced PKA-dependent changes
in the FRET/CFP ratio measured in ten individual
cells, expressed relative to R0, the ratio R (FRET/
CFP) measured at t = 0. Individual traces were
synchronized at the beginning of adhesion.
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Figure 3. CD3-Induced Calcium Responses
in 3A9 T Cells Are Potentiated by Transient
rises in cAMP
(A and B) The 3 s UV flash is indicated by a gray bar,
and anti-CD3 addition is indicated by arrows. Each
calcium trace is the mean of 46–52 single-cell
calcium responses. (A) The calcium response was
potentiated in cells previously loaded with 200 mM
DMNB-caged cAMP (thick line) in comparison
to unloaded cells (thin line). Inset: When AKAR2-
transfected 3A9 T cells loaded with 200 mM
DMNB-caged cAMP were illuminated with a 3 s
UV flash, a transient increase in the PKA-depen-
dent FRET/CFP ratio was observed. The trace
corresponds to the average of 35 individual record-
ings.
(B) The potentiation of the calcium response
observed in cells loaded with 50 mM DMNB-caged
cAMP decreased when the delay between the flash
and the addition of anti-CD3 increases increased
from 1 to 6 min.
(C and D) The amplitude of the calcium responses
is plotted relative to the control (unloaded cells
stimulated 1 min after the UV flash). Each bar corre-
sponds to the average ± SD of the mean amplitude
(25–52 individual cells) of two to nine individual
experiments. (C) The potentiation of the calcium
response depended upon the concentration of DMNB-caged cAMP and the delay between the flash and the stimulation. (D) Calcium responses were potentiated
in DMNB-caged cAMP loaded cells after UV uncaging (black bar) except if they had been previously incubated with H89 (20 mM, hatched bar). On the contrary,
when a mixture of FSK (13 mM) and IBMX (20 mM) was added to unloaded cells during the flash (striped bar), the anti-CD3-induced calcium response was reduced
in comparison to the control (gray bar). Statistical significance: *p < 0.05 or **p < 0.01.
Immunity
A Transient Rise in cAMP Sensitizes TCR Signalingstimulation (Figure 3B). The cAMP-dependent potentiation van-
ished even more rapidly when the concentration of DMNB-
caged cAMP was increased: with 200 mM DMNB-caged
cAMP, potentiation was detectable 1 min but not 3 min after
the flash. These results are summarized in Figure 3C.
Several control experiments were performed and yielded the
following conclusions. First, the amplification of the calcium
response was not a nonspecific consequence of the UV flash
because the same flash was applied to control cells that were
not loaded with DMNB-caged cAMP. Second, the potentiating
effect was specific to cAMP and cannot be explained by the
chemicals formed after UV-induced cleavage of the DMNB-
caged cAMP because no potentiation was observed after
cAMP was uncaged when PKA activity was blocked by H89
(Figure 3D). Finally, the shape of the cAMP response we gener-
ated was absolutely critical: if a sustained cAMP increase was
generated by the addition of FSK + IBMX to control cells simul-
taneously with the flash, the subsequent calcium response was
not increased in comparison to the control (Figure 3D). Alto-
gether, these results show that, depending on its kinetics,
a cAMP increase may have opposing effects on TCR signaling.
A robust and sustained increase in cAMP leads to an inhibition
of CD3-induced calcium response, whereas a transient cAMP
peak has a potentiating effect.
The cAMP Rise Controls ERK Activation and AITCP
through Inhibition of the Phosphatase HePTP
Next, we tested whether the adhesion-induced activation of ERK
was dependent on the increase in cAMP. As shown in Figure 4A,
the conspicuous ERK activation normally observed in adherent
T cells was strongly reduced after inhibition of adenylate cyclase36 Immunity 30, 33–43, January 16, 2009 ª2009 Elsevier Inc.(AC) and PKA with 20,50-dideoxyadenosine (ddA) and H89,
respectively. Similar results were obtained with ddA or H89
separately (data not shown). Conversely, ERK activation upon
adhesion was greatly enhanced in the presence of IBMX
(Figure S3). Forskolin, a potent activator of AC, induced a robust
activation of ERK in suspended T cells (Figure S3). Then, to test
whether the cAMP dependence of ERK activation had an impact
on AITCP, anti-CD3-induced calcium responses were compared
in suspended or adherent cells with or without inhibitors of the
cAMP pathway. Consistent with the effect on ERK activation,
the potentiation of anti-CD3-induced calcium responses was
suppressed in the presence of inhibitors of PKA activation
(Figure 4B). The same result was obtained with PKI, another
inhibitor of PKA (Figure S4).
Among the phosphatases that are able to dephosphorylate
ERK, Haematopoietic Protein Tyrosine Phosphatase (HePTP) is
an interesting candidate because it has been reported to be in-
activated by its PKA-dependent phosphorylation (Saxena
et al., 1999b). One could thus hypothesize that HePTP mediates
the potentiating effect of an adhesion-induced transient increase
in cAMP on ERK activation and calcium signaling. In order to test
the functional importance of HePTP directly, we transfected 3A9
murine T cells with a specific siRNA. Figure 4C (bottom) shows
that this transfection resulted in a clear reduction of HePTP
expression. This resulted in a conspicuous increase in ERK
phosphorylation 72 hr after the transfection (Figure 4C, top).
We next tested the functional consequences of this inhibition.
Figure 4D illustrates such an experiment, in which 3A9 T cells
transfected with a control siRNA (top row) responded poorly to
anti-CD3 stimulation but showed a large response after cAMP
was uncaged. In cells transfected with HePTP siRNA, a large
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Figure 4. ERK Activation and the Subse-
quent AITCP Is Dependent on PKA Activa-
tion and HePTP
The cAMP pathway was blocked by preincubation
of 3A9 T cells with 10 mM H89 and/or 40 mM ddA for
10 min before adhesion started.
(A) ERK activation upon adhesion was inhibited in
the presence of H89+ddA.
(B) Calcium responses were measured in sus-
pended (thin line) or 5 min-adherent-on-fibronectin
(thick line) 3A9 T cells after stimulation with 5mg/ml
anti-CD3 in control conditions or in the presence of
10 mM H89 plus 20 mM ddA. Inhibitors were added
10 min before the experiment. One experiment
typical of more than eight experiments is shown.
(C) Expression of a control protein, Sam68, and
HePTP (top) and of phospho-ERK (bottom) in cells
transfected 72 hr earlier with control siRNA or with
HePTP siRNA.
(D) Calcium responses elicited by anti-CD3
(arrows) in 3A9 T cells 72 hr after transfection with
a control siRNA (top row) or with a HePTP-specific
siRNA (bottom row). A UV flash (gray bar) was
applied 1 min before anti-CD3 stimulation. In the
right column, cells had been loaded with caged
cAMP; thus, the UV flash uncaged cAMP. In the
left column, the UV flash only served as a control
for potential UV-induced artifacts. One experiment
typical of five experiments is shown.
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A Transient Rise in cAMP Sensitizes TCR Signalinganti-CD3-induced calcium response was observed. This is
consistent with the prediction that inhibiting the phosphatase
that normally keeps the basal degree of ERK activity low should
increase ERK activity and thus facilitate TCR signaling. However,
when this cAMP-responsive element is inhibited, a cAMP
increase will mostly act on inhibitory pathways. Such an interpre-
tation is compatible with the observation that uncaging cAMP
inhibits the anti-CD3-induced calcium response in T cells with
low HePTP activity.T-DC Contact Triggers a cAMP Rise and Subsequent
ERK Activation
We have previously shown that antigen-independent T-DC inter-
actions often lead to small, transient calcium increases that may
be involved in the sensitization of the T cell for the detection of
rare antigenic peptides (Trautmann and Randriamampita,
2003) and be associated with DC-induced survival signals (Feuil-
let et al., 2005). In addition, when stimulated with anti-CD3,
T cells in contact with DCs display larger calcium rises than iso-
lated T cells (Randriamampita et al., 2003). This result suggests
that DCs are able to deliver a priming signal to T cells. We thus
looked at whether the signaling cascade involving cAMP and
ERK contributed to this signal. These experiments were
performed with primary peripheral blood human T cells (PBT)
transfected with the AKAR2 probe and interacting with in vitro
differentiated human DCs without any additional antigen or
superantigen.
A transient PKA activation occurring rapidly after initiation of
the contact was readily measurable in these T-DC conjugates
(Figures 5A and 6). The antigen-independent DC-induced
changes in PKA activity were even faster than those measured
upon interaction with fibronectin: PKA activity rose for about1 min, and by 3 min, PKA activity had returned close to basal
values in most cells, as shown in the synchronized average
(Figure 5B). In cases where a T cell made successive contacts
with two different DCs, distinct transient increases in PKA
activity were observed after each contact (Figure 5A). These
swift changes in the FRET/CFP ratio signal reflected specific
variations in PKA activity: when such variations were measured
in T cells in the presence of cAMP pathway inhibitors
(ddA+H89), the signal was entirely abolished (Figure 5B).
Furthermore, ERK was specifically activated at the T-DC
synapse, as detected via the localized labeling with anti-
phospho-ERK (Figure 5C). This labeling was markedly reduced
when the cAMP pathway has been blocked by preincubation
of the PBT with ddA and H89. Synaptic recruitment of phos-
pho-ERK, quantified in 65 T-DC conjugates, was significantly
decreased (p < 0.001) when T cells were treated with inhibitors
of PKA activation (Figure 5C). Taken together, these results
show that when a T cell interacts with a DC, independently of
any antigen detection, this contact triggers a transient cAMP
increase that is followed by synaptic ERK activation.The APC-Induced Increase in cAMP Is Necessary
for Increasing the Sensitivity of TCR Signaling
In order to compare the kinetics of PKA activation with those of
calcium responses, we measured the FRET/CFP ratio signal and
Fura-2 fluorescence simultaneously (Figure 6). We took care to
work with a low Fura-2 concentration in order to minimize the
crosstalk between the four different fluorescent signals. The
low-intensity signal, combined with the fact that we worked
with motile cells in order to catch the initial contact, prevents
the acquisition of low noise recordings. Nevertheless, a clear
conclusion emerges from these experiments: upon T-DCImmunity 30, 33–43, January 16, 2009 ª2009 Elsevier Inc. 37
Figure 5. cAMP Increase and ERK Activation Induced by T-DC Interaction
(A) Individual human PBTs transfected with AKAR2 display a rise in cAMP (as measured by a rise in the FRET/CFP ratio) when they contact mature DCs in the
absence of exogenous antigen. As shown on the two lower panels, successive contacts may all be activating. Arrows indicate the initial contact as judged from
the transmitted-light pictures.
(B) Average cAMP (FRET/CFP) responses observed in 19–28 individual T cells after synchronization at initial contact. No such rise occurs in T cells preincubated
with 10 mM H89 + 20 mM ddA for 15 min.
(C) p-ERK antibodies reveal ERK activation (marked by arrows) at the contact zone between PBTs and DCs (left) except when T cells were incubated with 10 mM
H89 and 20 mM ddA (middle). Quantification of synaptic recruitment of p-ERK in the absence (n = 41 conjugates) or presence (n = 24 conjugates) of ddA + H89
(right). The ordinate gives an index of synaptic recruitment, i.e., the ratio of p-ERK labeling at the synapse and in the rest of the cell (see Experimental Procedures).
Statistical significance: **p < 0.001.
Immunity
A Transient Rise in cAMP Sensitizes TCR Signalingcontact, the rise in cAMP-dependent FRET/CFP ratio always
precedes the calcium response. The average delay was 74 ±
21 s, (mean ± SEM, n = 8 ; Student’s t test, p < 0.01).
Next, in order to evaluate the physiological role of DC-induced
transient cAMP increases on the DC-induced calcium responses
of T cells, we tested the effect on these responses of preventing
PKA activation by simultaneously blocking adenylate cyclase
and PKA. Calcium responses were first measured in Marylin
T cells (TCR transgenic CD8 T cells recognizing a male antigen)
interacting with bone-marrow-derived DCs of male mice, i.e.,
presenting a physiological amount of antigen. Figure 6B shows
that the response measured in T cells in which PKA was inhibited
was markedly smaller than in control cells; the inhibiting effect
was exerted mostly on the probability of triggering a calcium
response in a conjugated T cell. Figure 6C gives the dose-
response curve for the calcium responses elicited in human
PBT interacting with Raji B cells loaded with various concentra-
tions of superantigen. Consistent with what has been shown
above, the dose-response curve is shifted toward larger super-
antigen concentrations under conditions where the cAMP38 Immunity 30, 33–43, January 16, 2009 ª2009 Elsevier Inc.pathway is inhibited, showing the importance of cAMP increases
for responding to TCR stimulations of low intensity.
Finally, we examined whether the adhesion-induced potentia-
tion of TCR signaling was detectable with readouts other than
the calcium response. We thus stimulated PBTs with Raji B cells
loaded or not loaded with 40 ng/ml of superantigen and 2 hr later
measured the fraction of conjugated cells in which a nuclear
translocation of NF-AT could be observed. Figure 7A shows
that the superantigen-induced translocation was inhibited in
cells in which PKA activation had been prevented. The fraction
of T cells expressing CD69 2 hr after superantigen stimulation
was also measured. Figure 7B shows that in control cells,
a peak of CD69-expressing cells was conspicuous. Because
only a fraction of PBTs have the appropriate Vb for responding
to superantigen and because not all PBT conjugated with Raji
B cells, it is not surprising that only a minority of superantigen-
stimulated PBTs expressed CD69. This CD69-positive popula-
tion completely disappeared when PKA activation was inhibited.
Taken together, these results show that the transient cAMP
increase occurring upon interaction of a T cell with an APC is
Figure 6. cAMP Increase during PBT and DC Contact Is Required for T Cell Sensitization
(A) Simultaneous calcium (top series of pictures) and PKA-dependent FRET/CFP recordings (middle series of pictures) in a AKAR2-transfected PBT contacting
a DC (lower series of pictures, where the arrows point to the T cell). The color scale goes from low (blue) to high (red) values of calcium or FRET/CFP ratios.
(B) Calcium responses elicited in Marylin T cells interacting with bone-marrow-derived DCs from a male mouse, in control conditions (black) or in T cells in which
PKA activation had been blocked by H89 + ddA. Traces correspond to a typical experiment in which the calcium response has been averaged from 30–46 cells
interacting with a DC. So that their true time course is better shown, the different responses have been time shifted and synchronized during their rising phase.
(C) Average calcium responses measured in one experiment in control conditions (black) or after treatment with H89 + ddA (red) in PBTs interacting with Raji B
cells loaded with 10–100 ng/ml superantigen. A second experiment exhibited a similar rightward shift of the dose-response curve measured in the presence of
inhibitors.
Immunity
A Transient Rise in cAMP Sensitizes TCR Signalingnecessary for an optimal TCR signaling, as measured with
several readouts.
DISCUSSION
We have described here that after adhesion, the sensitizing
signal leading to enhanced TCR signaling is initially due to an
unexpected cAMP increase, causing an increase in ERK activa-
tion. This conclusion arises from an ensemble of observations:
(1) adhesion induces both a cAMP increase and ERK activation;
(2) adhesion-induced ERK activation is cAMP dependent and
due to an inhibition of an ERK phosphatase; (3) AITCP may be
blocked by inhibitors of either ERK activation or cAMP increase.
A sustained increase in cAMP after integrin signaling has been
reported in other cell types, such as endothelial cells (Fong and
Ingber, 1996; Meyer et al., 2000), monocyte-derived DCs
(Burzyn et al., 2002), human fibrosarcoma cells (Whittard and
Akiyama, 2001), and carcinoma cells (O’Connor and Mercurio,
2001), but in no case were its kinetics established at thesingle-cell level and with an accuracy such as that allowed by
a FRET-based probe. In the present work, we have demon-
strated that upon interaction of a T cell with an APC, a transient
increase in PKA activity, likely to reflect a transient rise in cAMP,
is triggered very rapidly in the T cell, on average 1 min before the
calcium response.
It was quite unexpected that an increase in cAMP could
contribute to the phenomenon of AITCP. With the exception of
one paper in which a cAMP increase, triggered by plate-bound
anti-CD3 plus anti-CD28, favored the secretion of IL-4 and IL-5,
but not that of IL-2 and IFN-g (Kanda et al., 2001), the vast
majority of the reports tend to show that cAMP increases exert
an inhibitory effect on lymphocyte activation, of both B (Venka-
taraman et al., 1998) and T lymphocytes (Hermann-Kleiter
et al., 2006; Tamir et al., 1996; Vang et al., 2003). The exact
nature of the inhibition of anti-CD3-induced T cell responses
exerted by sustained increases in cAMP (e.g., by forskolin) is
far from clear, but it might involve activation of Csk, a well-
described Lck inhibitor (Vang et al., 2001), or an inhibition ofImmunity 30, 33–43, January 16, 2009 ª2009 Elsevier Inc. 39
Figure 7. cAMP Dependence of PBT Responses
2 hr after Stimulation with Superantigen
PBTs treated or not treated with ddA + H89 were mixed
with Raji B cells loaded with 40 ng/ml superantigen. Two
hours later, two readouts were measured.
(A) Nuclear translocation of NF-AT in T-B conjugates.
Localization of the probes was measured in 30–70 T cells
per experiment as pericellular, diffuse, or nuclear, and in
each condition the ratio was averaged: (nuclear +
diffuse)/pericellular. Ratios were normalized to the value
found in unstimulated cells, not treated with inhibitors.
The mean ± SD of three experiments is shown. Statistical
significance: **p < 0.02, *p < 0.05.
(B) Graphs show the level of CD69 staining on gated PBT
cells. CD69 expression in cells treated (bold line) or not
treated (gray histograms) with inhibitors, in the absence
(top) or presence (bottom) of superantigen. One experi-
ment typical of three experiments is shown.
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et al., 1992). We have shown that the kinetics of a cAMP increase
constitute a key issue. A transient cAMP increase, either elicited
upon formation of an immunological synapse or triggered in sus-
pended cells with a photoactivatable cAMP, is clearly activating.
This is one more example of a unique stimulus that may trigger
both activation and inactivation or desensitization.
We have not analyzed the immediate target of the cAMP
increase in detail. PKA is an obvious candidate, and this possi-
bility is sustained by the effects of H89, an inhibitor of this kinase,
on AITCP. However, it should be noted that PKA is not the only
cAMP effector. Additional effectors are EPACs (exchange
proteins directly activated by cAMP), which catalyze the activa-
tion of the Rap family of small G proteins (Bos et al., 2001).
Because Rap proteins play an important role in cell attachment
and migration, it is worth examining a potential role of the
EPAC-Rap1 pathway in AITCP.
The cAMP-dependent ERK activation does not occur through
the Ras-MEK cascade because, on the contrary, cAMP-
dependent inhibition of MEK activation has been reported and
could result from the uncoupling of Raf-1 from Ras activation,
either by direct action of PKA on Raf-1 or through the action of
PKA on the GTPase Rap1 (Stork and Schmitt, 2002). This is
consistent with the small reduction we have observed in MEK
phosphorylation induced by adhesion (Figure S1). Our data indi-
cate that the cAMP-dependent ERK activation results form the
inhibition of one or more ERK phosphatases, HePTP being
a major one. This should potentially allow a partial ERK activa-
tion, in contrast to the Ras-MEK cascade, that functions in an
almost all-or-none way because it results from a cascade of
cooperative mechanisms (Huang and Ferrell, 1996), (Altan-
Bonnet and Germain, 2005).
So far, we have only mentioned ERK activation after adhesion.
However, at the immunological synapse ERK activation also
results from the TCR signaling cascade itself. It has been shown
that this cascade includes two feedback mechanisms, a negative
one mediated by the phosphatase SHP-1, which is recruited in
the signalosome, where it dephosphorylates and inactivates
Lck, and a positive one, mediated by ERK, which phosphorylates40 Immunity 30, 33–43, January 16, 2009 ª2009 Elsevier Inc.Lck in a way that protects it from the action of SHP-1 (Stefanova
et al., 2003). Thus, at an immunological synapse, before any
antigen is detected, ERK may be first activated in an adhesion-
and cAMP-dependent way. Upon antigen detection and TCR
triggering, this early ERK activation is expected to help the surge
of a large calcium response. After PKA has been turned off, a sus-
tained ERK activation is expected to take place as a direct
consequence of TCR signaling.
Several questions remain to be solved. How is AITCP trig-
gered? Because this phenomenon can be observed in T cells
adhering to very different substrates (glass, fibronectin,
antibodies against MHC I or b2 integrins) (Randriamampita
et al., 2003), one must conclude that there is not a unique
membrane receptor able to transduce adhesion into an amplified
calcium response and that instead AITCP depends on a common
signalosome that may be recruited upon adhesion mediated by
various surface molecules, including b1 or b2 integrins. The
composition of this signalosome still needs to be established.
What are the molecular steps leading to AC activation and/or
PDE inhibition after adhesion? The question is open, and the
involvement of Gas protein has been proposed (Meyer et al.,
2000). How does ERK activation lead to an increase of the
CD3-induced calcium response? We have previously shown
that AITCP could be mediated by a rapid increase in cellular
PIP2 and by a simultaneous increase of endogenous calcium
reserves (Randriamampita et al., 2003). It is possible that one
or both of these events are under the control of ERK activation,
in addition to the protective effect exerted on Lck for preventing
its inactivation by SHP-1, as mentioned above.
Concerning the physiological relevance of this unexpected
effect of cAMP, we have shown that, in different experimental
settings, in vitro DC-induced calcium responses were severely
inhibited under conditions where the cAMP increase was
inhibited. We make the hypothesis that this cAMP-dependent
sensitization of T cells takes place in lymph nodes, where it might
contribute to the extraordinary ability of T cells to detect very
small numbers of peptide-MHC complexes in immunological
synapses. Within a lymph node, T cells move along a network
formed by FRCs (fibroblastic reticular cells) (Bajenoff et al.,
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a recent review, ‘‘the FRC network forms a chemokinetic surface
that keeps the T cell dynamic’’ (La¨mmermann and Sixt, 2008).
This phenomenon is probably related to the facts that CCL21,
which promotes T cell motility (Asperti-Boursin et al., 2007), is
immobilized on the FRC network and that the basement
membrane of FRCs is not exposed toward the T cell zone but
toward the inside of the fiber (La¨mmermann and Sixt, 2008). If
T cells move when they are in contact with the FRC network
and stop for variable durations upon interaction with DCs, it is
probably because DCs are much stickier than FRC for T cells,
as a result of the variety and the abundance of DC surface mole-
cules that are able to interact with T cells. One can thus make the
hypothesis that the cAMP- and ERK-dependent priming signal is
only delivered by DCs, which are also the only cells able to
deliver to T cells a stop signal in the absence of antigen (As-
perti-Boursin et al., 2007; Revy et al., 2001). In line with our
observation that multiple transient cAMP increases can be
measured in a T cell interacting successively with several DCs,
it is quite conceivable that within lymph nodes, depending on
whether they interact with DCs, T cells could thus cycle between
states of low and high sensitivity for TCR signaling, and the tran-
sient state of higher sensitivity could be repeated many times
during the sojourn of a T cell within a lymph node. Even though
the specific consequences of the light adhesion to stromal cells
and stronger adhesion to DCs deserves to be studied in more
detail, our results allow us to conclude that a cascade of
T cell-adhesion-triggered events, including a transient rise in
cAMP and successive ERK activation, is essential for optimizing
T cell signaling. When it comes to considering cAMP increases in
T cells, it will now be absolutely necessary to distinguish
between transient increases, which have potentiating effects,
and sustained increases, which have inhibitory effects.
EXPERIMENTAL PROCEDURES
Cells
3A9 cells were kindly provided by Annemarie Lellouch (CIML, Marseille).
PBTs were purified as previously described (Real et al., 2004). Human
dendritic cells were differentiated in vitro as reported in (Real et al., 2004)
and cultured at 2.106/ml in AIMV supplemented with IL13 (15 ng/ml) and
GM-CSF (500 U/ml). The day before the experiment, 2.105 cells were trans-
ferred to glass-bottomed Petri dishes and matured by the addition of FMKP
(1 mg/ml) and IFNg (500 U/ml) to the culture medium. Marylin T cells were
obtained after spleen dissociation. Bone-marrow-derived DCs were purified
as previously reported (Benvenuti et al., 2004).
Mice
Animal care was performed by expert technicians in compliance with relevant
law and institutional guidelines. Marylin mice were obtained from the CNRS
animal facility (Centre de Distribution, Typage & Archivage Animal, Orleans).
Reagents and Antibodies
U0126, ddA, H89, IBMX, forskolin, and PKI were from Calbiochem, Fura-2/AM
and DMNB-caged cAMP were from Molecular Probes, CPT-cAMP, dBt-
cAMP, PMA, and superfibronectin were from Sigma (superfibronectin is
a formulation of recombinant human fibronectin fragment III1-C with human
plasma fibronectin), anti-ERK1/2, anti-CD3 and anti-NF-AT were from Phar-
Mingen, anti-(Y/T)p-ERK was from Sigma, anti-Phospho-MEK was from Cell
Signaling, anti-HePTP was from Abcam and Santa Cruz, anti-Sam68 was
from Santa Cruz, and anti-CD69-PE was from BD Biosciences. For immunoflu-
orescence, anti-p-ERK was purchased from Cell Signaling and goat anti-mouse IgG coupled with Rhodamin RedX was from Jackson Laboratories.
Recombinant phosphorylated His6-ERK-2 was from Biomol. ERK immunopre-
cipitation was performed with an anti-ERK2 directly coupled to agarose from
Santa Cruz. Cell adhesion was performed on glass coverslips coated with
superfibronectin (5 mg/ml, 30 min at 37C). AKAR2 was kindly provided by
R.Y. Tsien. Stimulating mouse anti-human anti-CD3 (UCHT1) and anti-mouse
anti-CD3 (2C11) were form BD PharMingen.
Preparation of Cell Lysates, Immunoblotting,
and Immunoprecipitation
For immunoblotting, in brief, after cell lysis and removal of cell debris, samples
were separated by SDS-PAGE in a 10% acrylamide gel and transferred to
a PDF membrane. After blocking and labeling with antibodies, peroxydase
labeling was revealed with an enhanced chemiluminescence system. The
intensity of phospho-ERK and that of Sam68 for normalization were quantified
with Metamorph (Universal Imaging, Western Chester, PA). See Supplemental
Data for more details.
ERK Phosphatase Assay
This assay was performed as described in (Laakko and Juliano, 2003). In brief,
cells were lysed in phosphatase lysis buffer (0.1% Triton X-100, 0.3 M sucrose,
50 mM Tris-HCl [pH 7.5], 100 mM KCl, 1 mM CaCl2, 2.5 mM MgCl2, and
a protease inhibitor cocktail [complete EDTA-free, Roche]). Cell extract
(150 mg/sample) was diluted 1:4 in phosphatase assay buffer (10 mM MgCl2,
10 mM HEPES [pH 7.4], and 10 mM UO126). Recombinant phosphorylated
His6-ERK-2 was added at 30 ng/sample and incubated for 20 min at room
temperature. The addition of urea (8 M [pH 8.6]) containing 10 mM imidizole
stopped the reaction, and the samples were placed on ice. The His-ERK
was precipitated by the addition of nickel-conjugated agarose (30 ml), and
samples were incubated overnight at 4C. The samples were then washed
three times in 8 M urea (pH 6.8) and 10 mM imidizole and twice in 300 mM
NaCl2 and 25 mM Tris (pH 7.5). The amount of phosphorylated His-ERK re-
maining was then determined by immunoblot analysis with antibodies against
dually phosphorylated ERK and total ERK for controlling the protein level.
HePTP Knockdown
3A9 cells were nucleofected (AMAXA program X001) with a HePTP targeted
siRNA or irrelevant siRNA at a concentration of 1 mg siRNA per 2.53 106 cells
(on-TARGETplus SMARTpool siRNAs from Dharmacon). After nucleofection,
cells were incubated for 10 min at 37C with RPMI without serum and
subsequently resuspended in RPMI supplemented with 10% FCS. Depletion
efficiency was analyzed by immunoblotting.
Calcium Measurements
T cells were incubated for 20 min at 37C with 1.5 mM Fura-2/AM (Molecular
Probes). Measurements were performed in mammalian saline. Calcium
measurements by spectrofluorimetry were performed as previously described
(Randriamampita et al., 2003) with a Cary Eclipse spectrofluorimeter (Varian)
(excitation: 340 and 380 nm; emission: 510 nm). For adherent T cells, 100 ml
of Fura-2-loaded T cells in a serum-free culture medium were let to adhere
for 5–10 min on a glass coverslip coated with fibronectin. The coverslip was
introduced in the cuvette with an angle appropriate for avoiding reflection of
the excitation light. Cells were stimulated with 3–5 mg/ml anti-CD3.
cAMP Dependence of Responses to Superantigen
PBTs untreated or treated with 20 mM ddA (30 min) and 10 mM H89 (for the last
10 min) were added to Raji B cells pulsed for 30 min with a superantigen mix,
i.e., a mixture of staphyloccal enterotoxin A, B, C3, and E (Toxin Technology).
Cells were mixed at a PBT:Raji ratio of 2:1 and kept at 37C for 2 hr. For CD69
experiments, cell contact was forced by centrifugation.
cAMP Measurements or PKA Activity
Measurements of cAMP on cell populations were performed with an HTRF
(Homogeneous Time-Resolved Fluorescence) assay with cAMP kits (Cisbio,
Bedford, USA) (detailed protocol is available in the Supplemental Data).
Measurement of PKA activity at the single-cell level was performed in cells
transfected the day before the experiment with the AKAR2 probe (Zhang
et al., 2005; Zhang et al., 2001) by nucleofection (AMAXA, program U14 forImmunity 30, 33–43, January 16, 2009 ª2009 Elsevier Inc. 41
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acquisition was done with a Nikon TE2000 equipped with a cooled CCD
camera (Cascade, Princeton Instruments). This probe does not directly detect
an increase in cAMP but rather detects an immediate consequence of this
increase, i.e., an increase in PKA activity. In the presence of activated PKA,
the probe undergoes a conformational change that allows an energy transfer
between a CFP molecule (excitation [ex] 436 nm, emission [em] 470 nm) and
a YFP molecule (ex 500 nm, em 535 nm); this energy transfer can be measured
as a change in FRET (ex 436 nm, em 535 nm). Three images were acquired
every 10 s: visible and with excitation at 436 nm with emission successively
at 535 nm (FRET) and 470 nm (CFP). The ratio R = FRET/CFP, which gives
a normalized estimate of PKA activity, was calculated with MetaFluor (Roper
Scientific) after background substraction.
DMNB-Caged cAMP Experiments and Combined Calcium and cAMP
Measurements
3A9 T cells were incubated with 50–200 mM DMNB-caged cAMP for 2 hr before
a 20 min loading period with 1 mM Fura-2/AM. DMNB-caged cAMP was
uncaged by a 3 s intense illumination of the whole field at 360 nm. For simul-
taneous calcium and cAMP measurements, the concentration of Fura-2/AM
was reduced to 50 nM (20 min at 37C) so that the cross-talk between the
four fluorescence signals would be minimized. Image acquisition was
performed as previously described (Randriamampita et al., 2003). Five images
were acquired every 10 s: transmitted light image, calcium measurement (exci-
tation at 350 and 380 nm with emission at 510 nm), and FRET/CFP ratio
measurements (see previous paragraph). Calcium concentrations were
expressed as a plot of the ratio 340/380 after background substraction.
Immunofluorescence
PBTs (5.105) were added to a monolayer of mature DCs. After 20 min of
contact at 37C, cells were fixed with 4% paraformaldehyde in PBS + 0.5%
BSA for 20 min, then permeabilized with 0.1% saponin in PBS + 0.5% BSA.
Anti-p-ERK or anti-NF-AT and then goat anti-mouse coupled with Rhodamin
RedX antibodies were incubated at room temperature (30 min each). Fluores-
cence images were acquired with a Nikon TE300 microscope equipped with
a cooled CCD camera (CoolSnapHq) and Metamorph software. For quanti-
fying the relative amount of phospho-ERK at the immunological synapse,
the intensity of pERK labeling was measured both at the synapse and in
a region away from the synapse, and the ratio between these two average
intensities was calculated (see Figure 5C).
SUPPLEMENTAL DATA
Supplemental Data include Supplemental Experimental Procedures and four
figures and are available with this article online at http://www.immunity.com/
supplemental/S1074-7613(08)00551-7.
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